Charter Communications Revises Buyout Offer for Liberty Broadband Under Improved Terms General Motors Introduces AllElectric Cadillac Vistiq with 300Mile Range The One Rule That Can Help Investors Avoid Sophisticated Financial Scams Norway Accelerates Oil and Gas Expansion Amid Europes Energy Security Push SP 500 Edges Higher as Healthcare and Technology Lead BroadBased Gains Berkshire Hathaway Increases Alphabet Stake by 224 and Takes 26 Billion Position in Delta Air Lines Hancock Whitney Q1 2026 Earnings Slight EPS Beat Amidst Cautious Outlook Veris Residential Inc Q4 2025 Earnings NarrowerThanExpected Loss Signals Operational Progress Customers Bancorp Inc CUBI Q1 2026 Earnings Modest EPS Beat Amid Quiet Quarter AEHL Q3 2012 Earnings EPS Beats Estimates by 768 Amid Steep Stock Decline MGE Energy Q1 2026 Earnings EPS Beat Driven by Operational Strength MFIN Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Scienjoy Holding SJ Rises 242 as Stock Tests Key Resistance Level CanFite Biopharma CANF Slides 262 Toward 318 Support as Selling Pressure Persists BULLW Warrants Slide 954 as Webulls Equitylinked Securities Test Key Support Immunome IMNM Edges Higher as Stock Consolidates Near Key Resistance Level ECCX Remains Nearly Flat at 2517 as FixedIncome Note Holds Steady SP 500 Extends Longest Winning Streak Since 2023 Dow Jones Surges Over 2 for the Week CASS Q1 2026 Earnings EPS Beats Estimates by Nearly 6 Stock Edges Lower Voya Global Advantage and Premium Opportunity Fund IGA Holds Steady at 988 Amid RangeBound Trading Wall Street Poised for Weekly Gains as Markets Overcome Early Bond Market Jitters Prediction Markets Point to Potential Federal Reserve Rate Hike by July 2027 Northrop Grumman NOC Q1 2026 Earnings Defense Contractor Beats EPS Estimates Amid Steady Demand El Pollo Loco Q1 2026 Earnings EPS Surges Past Estimates with 2756 Beat Immatics NV IMTX Q1 2026 Earnings WiderThanExpected Loss Amid Clinical Progress Tokenization May Create Free Market in Capital Says Strategys Michael Saylor Adagene Q2 2025 Earnings Clinical Progress Overshadows EPS Miss Shares Jump